Zurich Insurance Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.9M | Buy |
+22,651
| New | +$11.9M | 0.09% | 130 |
|
2025
Q1 | – | Sell |
-23,784
| Closed | -$16.9M | – | 292 |
|
2024
Q4 | $16.9M | Sell |
23,784
-39,857
| -63% | -$28.4M | 0.14% | 129 |
|
2024
Q3 | $66.9M | Sell |
63,641
-28,709
| -31% | -$30.2M | 0.57% | 60 |
|
2024
Q2 | $97.1M | Buy |
92,350
+39,382
| +74% | +$41.4M | 0.84% | 30 |
|
2024
Q1 | $51M | Buy |
52,968
+20,736
| +64% | +$20M | 0.47% | 73 |
|
2023
Q4 | $28.3M | Sell |
32,232
-47,092
| -59% | -$41.4M | 0.29% | 103 |
|
2023
Q3 | $65.3M | Buy |
+79,324
| New | +$65.3M | 0.69% | 49 |
|
2019
Q4 | – | Sell |
-14,187
| Closed | -$3.94M | – | 434 |
|
2019
Q3 | $3.94M | Buy |
14,187
+468
| +3% | +$130K | 0.07% | 277 |
|
2019
Q2 | $4.29M | Buy |
13,719
+541
| +4% | +$169K | 0.09% | 262 |
|
2019
Q1 | $5.41M | Sell |
13,178
-15,620
| -54% | -$6.41M | 0.12% | 219 |
|
2018
Q4 | $10.8M | Buy |
28,798
+5,471
| +23% | +$2.04M | 0.26% | 114 |
|
2018
Q3 | $9.43M | Sell |
23,327
-75
| -0.3% | -$30.3K | 0.2% | 140 |
|
2018
Q2 | $8.07M | Buy |
23,402
+13,625
| +139% | +$4.7M | 0.18% | 162 |
|
2018
Q1 | $3.37M | Sell |
9,777
-1,443
| -13% | -$497K | 0.08% | 310 |
|
2017
Q4 | $4.22M | Buy |
11,220
+1,379
| +14% | +$518K | 0.1% | 247 |
|
2017
Q3 | $4.4M | Sell |
9,841
-2,276
| -19% | -$1.02M | 0.12% | 202 |
|
2017
Q2 | $5.95M | Sell |
12,117
-561
| -4% | -$276K | 0.17% | 147 |
|
2017
Q1 | $4.91M | Sell |
12,678
-483
| -4% | -$187K | 0.14% | 179 |
|
2016
Q4 | $4.83M | Buy |
13,161
+945
| +8% | +$347K | 0.15% | 170 |
|
2016
Q3 | $4.91M | Buy |
12,216
+3,539
| +41% | +$1.42M | 0.16% | 166 |
|
2016
Q2 | $3.03M | Buy |
8,677
+1,442
| +20% | +$504K | 0.11% | 221 |
|
2016
Q1 | $2.61M | Sell |
7,235
-11,830
| -62% | -$4.26M | 0.09% | 238 |
|
2015
Q4 | $10.4M | Buy |
19,065
+1,271
| +7% | +$690K | 0.37% | 81 |
|
2015
Q3 | $8.28M | Buy |
+17,794
| New | +$8.28M | 0.3% | 111 |
|